John Groetelaars

John Groetelaars brings more than 30 years of global leadership experience across a broad range of medical device sectors. Most recently he was interim CEO for Dentsply Sirona (Nasdaq: XRAY), having previously served in a director role for the company. Prior to Dentsply Sirona John was President & CEO at Hillrom from May 2018 until the company’s acquisition by Baxter International, Inc. in 2021. At Hillrom, he provided global leadership for a healthcare technology company with $3 billion in revenue and 10,000+ employees. Prior to joining Hillrom, John served as executive vice president and president of the Interventional Segment at Becton, Dickinson and Company (BD) following its acquisition of C.R. Bard in December 2017. Earlier in his career, John held various international leadership positions at Boston Scientific Corporation in Canada, Denmark and the UK as well as with Guidant Corporation and Eli Lilly. He earned a bachelor’s degree in Mechanical Engineering from Kettering University in Michigan and an MBA from Columbia University in New York.